
    
      Study Design and Location:

      Investigators propose a double blinded, randomized (1:1), placebo-controlled, multicenter,
      clinical trial including patients with acute aSAH. Participants will be allocated either to
      MgSO4 or placebo. The permission to conduct the study protocol will be considered for
      approval by the ethics committee of General Committee of Teaching Hospitals and Institutes
      (GCTHI), Egypt. The study will be conducted in 3 centers; El-Materia Educational Hospital,
      Ain Shams University Hospitals and Nasr City Insurance Hospital. The assigned centers for
      this study represent large-volume referral stroke centers that provide comprehensive
      management protocols for aSAH.
    
  